<SEC-DOCUMENT>0001213900-26-005370-index.html : 20260120
<SEC-HEADER>0001213900-26-005370.hdr.sgml : 20260120
<ACCEPTANCE-DATETIME>20260120074338
ACCESSION NUMBER:		0001213900-26-005370
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20260120
FILED AS OF DATE:		20260120
DATE AS OF CHANGE:		20260120

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LakeShore Biopharma Co., Ltd.
		CENTRAL INDEX KEY:			0001946399
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41598
		FILM NUMBER:		26541146

	BUSINESS ADDRESS:	
		STREET 1:		BUILDING NO. 2, 38 YONGDA ROAD
		STREET 2:		DAXING BIOMEDICAL INDUSTRY PARK
		CITY:			DAXING DISTRICT, BEIJING
		STATE:			F4
		ZIP:			102629
		BUSINESS PHONE:		17327133678

	MAIL ADDRESS:	
		STREET 1:		BUILDING NO. 2, 38 YONGDA ROAD
		STREET 2:		DAXING BIOMEDICAL INDUSTRY PARK
		CITY:			DAXING DISTRICT, BEIJING
		STATE:			F4
		ZIP:			102629

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YS Biopharma Co., Ltd.
		DATE OF NAME CHANGE:	20230310

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YishengBio Co., Ltd
		DATE OF NAME CHANGE:	20220912
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea0273285-6k_lakeshore.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
Document 1 - file: ea0273285-6k_lakeshore.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea027328502ex99-1_lakeshore.htm
<DESCRIPTION>PRESS RELEASE - LAKESHORE BIOPHARMA TO HOLD EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
<TEXT>
Document 2 - file: ea027328502ex99-1_lakeshore.htm

</DOCUMENT>
</SEC-DOCUMENT>